Trademark Overview
On Wednesday, February 5, 2025, a trademark application was filed for ACSTRYVE with the United States Patent and Trademark Office. The USPTO has given the ACSTRYVE trademark a serial number of 99029897. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Wednesday, February 5, 2025. This trademark is owned by RayzeBio, Inc.. The ACSTRYVE trademark is filed in the Pharmaceutical Products category with the following description:
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, hepatological, respiratory, neurological, gastrointestinal, dermatological, psychiatric, and immune system related diseases and disorders; diagnostic radiopharmaceutical preparations.